Loading publications…
The last 5 uploaded publications
Immunomodulatory Effects of Lenvatinib Plus Anti–Programmed Cell Death Protein 1 in Mice and Rationale for Patient Enrichment in Hepatocellular Carcinoma
Laura Torrens, Carla Montironi, Marc Puigvehí, Agavni Mesropian, Jack Leslie, Philipp K. Haber, Miho Maeda, Ugne Balaseviciute, Catherine E. Willoughby, Jordi Abril‐Fornaguera, Marta Piqué‐Gili, Miguel Torres‐Martín, Judit Peix, Daniel Geh, Erik Ramón-Gil, Behnam Saberi, Scott L. Friedman, Derek A. Mann, Daniela Sia, Josep M. Llovet (2021). Immunomodulatory Effects of Lenvatinib Plus Anti–Programmed Cell Death Protein 1 in Mice and Rationale for Patient Enrichment in Hepatocellular Carcinoma. Hepatology, 74(5), pp. 2652-2669, DOI: 10.1002/hep.32023.
Article145 days agoCabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma
Roger Esteban-Fabró, Catherine E. Willoughby, Marta Piqué‐Gili, Carla Montironi, Jordi Abril‐Fornaguera, Judit Peix, Laura Torrens, Agavni Mesropian, Ugne Balaseviciute, Francesc Miró‐Mur, Vincenzo Mazzaferro, Roser Pinyol, Josep M. Llovet (2022). Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma. Clinical Cancer Research, 28(11), pp. 2449-2460, DOI: 10.1158/1078-0432.ccr-21-2517.
Article145 days agoEpigenetic inactivation of the 5-methylcytosine RNA methyltransferase NSUN7 is associated with clinical outcome and therapeutic vulnerability in liver cancer
Vanessa Ortiz-Barahona, Marta Soler, Verónica Dávalos, Carlos A. García‐Prieto, Maxime Janin, Fernando Setién, Irene Fernández-Rebollo, Joan Josep Bech‐Serra, Carolina de la Torre, Sònia Guil, Alberto Villanueva, Peihong Zhang, Li Yang, Marco Guarnacci, Ulrike Schümann, Thomas Preiß, Ugne Balaseviciute, Robert Montal, Josep M. Llovet, Manel Esteller (2023). Epigenetic inactivation of the 5-methylcytosine RNA methyltransferase NSUN7 is associated with clinical outcome and therapeutic vulnerability in liver cancer. Molecular Cancer, 22(1), DOI: 10.1186/s12943-023-01785-z.
Article145 days agoTHU-077-YI E7386 enhances lenvatinib’s antitumor efficacy and upregulates ATF4 signalling in preclinical models and human hepatocellular carcinoma
Agavni Mesropian, Albert Gris‐Oliver, Ugne Balaseviciute, Martí Torres-Marcen, Jordi Abril‐Fornaguera, Marta Piqué‐Gili, David Camell, Judit Peix, Elisa Fernández-Martínez, Júlia Huguet‐Pradell, Ieva Keraite, Roger Esteban-Fabró, Takayuki Kimura, Alka A. Potdar, Marina Bárcena‐Varela, Katherine E. Lindblad, Amaia Lujambio, Ernesto Guccione, Swan N. Thung, Daniela Sia, Roser Pinyol, Josep M. Llovet (2025). THU-077-YI E7386 enhances lenvatinib’s antitumor efficacy and upregulates ATF4 signalling in preclinical models and human hepatocellular carcinoma. Journal of Hepatology, 82, pp. S431-S432, DOI: 10.1016/s0168-8278(25)01237-1.
Article145 days agoSAT-113 The intratumoral microbiome in HCC and its impact on treatment response
Ugne Balaseviciute, Mohammad Rahbari, Fabian Springer, Roser Pinyol, Roger Esteban-Fabró, Albert Gris‐Oliver, Marta Piqué‐Gili, Agavni Mesropian, Jessica Zucman‐Rossi, Jeanin E. van Hooft, Josep M. Llovet, Mathias Heikenwälder (2025). SAT-113 The intratumoral microbiome in HCC and its impact on treatment response. Journal of Hepatology, 82, pp. S463-S463, DOI: 10.1016/s0168-8278(25)01307-8.
Article145 days ago